Cytek Biosciences Inc. Watch

from 10-Q 2 pages Material contract

from 10-Q 15 pages Cytek Biosciences, Inc. Second Amended and Restated Severance Benefit Plan and Summary Plan Description

from 8-K 4 pages February 22, 2024 William (Bill) McCombe Wdmccombe@gmail.com Dear Bill, Cytek Biosciences, Inc. (“Cytek” or the “Company”) Is Pleased to Offer You the Position of Chief Financial Officer. You Will Serve as Principal Financial and Accounting Officer for Purposes of SEC Reporting. You Will Report to Wenbin Jiang, CEO, on Your Duties at Cytek. You Will Work at 47215 Lakeview Boulevard, Fremont, Ca 94538. the Company May Change Your Position, Duties, and Work Location From Time to Time as It Deems Necessary

from 10-Q 3 pages Material contract

from 10-K 72 pages Asset Purchase Agreement Among: Cytek Biosciences, Inc., a Delaware Corporation and Luminex Corporation, a Delaware Corporation Dated as of February 13, 2023

from 10-Q 21 pages Cytek Biosciences, Inc. Rsu Award Grant Notice

from 10-Q 20 pages Cytek Biosciences, Inc. Stock Option Grant Notice

from 8-K 3 pages October 4, 2022 Chris Williams Dear Chris, Cytek Biosciences, Inc. (“Cytek” or the “Company”) Is Pleased to Offer You the Position of Chief Operating Officer. You Will Report to Wenbin Jiang, CEO, on Your Duties at Cytek. You Will Work at 47215 Lakeview Boulevard, Fremont, Ca 94538. the Company May Change Your Position, Duties, and Work Location From Time to Time as It Deems Necessary

from 10-Q 9 pages Cytek Biosciences, Inc. Rsu Award Grant Notice

from 10-Q 16 pages Supply Agreement

from S-1/A 12 pages Cytek Biosciences, Inc. 2021 Amended and Restated Severance Benefit Plan and Summary Plan Description

from S-1/A 12 pages Indemnity Agreement

from S-1/A 13 pages Cytek Biosciences, Inc. 2021 Employee Stock Purchase Plan Adopted by the Board of Directors: , 2021 Approved by the Stockholders: , 2021 Ipo Date: , 2021

from S-1/A 10 pages Cytek Biosciences, Inc. Stock Option Grant Notice

from S-1/A 29 pages Cytek Biosciences, Inc. 2021 Equity Incentive Plan Adopted by the Board of Directors: , 2021 Approved by the Stockholders: , 2021

from S-1 49 pages II Lease Article 1 Reference Data

from S-1 18 pages Air Commercial Real Estate Association Standard Industrial/Commercial Multi-Tenant Lease - Net

from S-1 32 pages Settlement, License, and Equity Issuance Agreement

from S-1 34 pages Supply & License Agreement

from S-1 2 pages Patrik Sebastian Jeanmonod Re: Chief Financial Officer Dear Patrik, Cytek BioSciences Inc. (“Cytek” or the “Company”) Is Pleased to Offer You the Position of Chief Financial Officer (CFO). Your Duties Are Captured in the Attached Job Description. You Will Report to Dr. Wenbin Jiang, CEO of Cytek BioSciences. You Will Work in the Facility Located at 46107 Landing Parkway, Fremont, Ca 94538. Company May Change Your Position, Duties, and Work Location From Time to Time as It Deems Necessary. Your Annual Compensation Will Be $230,000 Less Payroll Deductions and All Required Withholdings. You Will Be Paid Semi-Monthly and You Will Be Eligible for the Following Standard Company Benefits